Southeast Asian ovalocytosis

Medical condition

Southeast Asian ovalocytosis

Specialty| Hematology

Southeast Asian ovalocytosis is a blood disorder that is similar to, but distinct from hereditary elliptocytosis.[1] It is common in some communities in Malaysia and Papua New Guinea, as it confers some resistance to cerebral Falciparum Malaria.[2]

## Pathophysiology

[edit]

### Southeast Asian ovalocytosis

[edit]

It is hereditary hemolytic anaemia in which the red blood cell is oval-shaped. The primary defect in SAO differs significantly from other forms of elliptocytosis in that it is a defect in the gene coding for a protein that is not directly involved in the cytoskeleton scaffolding of the cell. Rather, the defect lies in a protein known as the band 3 protein, which lies in the cell membrane itself. The band 3 protein normally binds to another membrane-bound protein called ankyrin, but in SAO this bond is stronger than normal. Other abnormalities include tighter tethering of the band 3 protein to the cell membrane, increased tyrosine phosphorylation of the band 3 protein, reduced sulfate anion transport through the cell membrane, and more rapid ATP consumption. These (and probably other) consequences of the SAO mutations lead to the following erythrocyte abnormalities:[3]

* A greater robustness of cells to a variety of external forces, including:
* Reduction in cellular sensitivity to osmotic pressures
* Reduction in fragility related to temperature change
* greater general rigidity of the cell membrane
* Loss of sensitivity to substances that cause spiculation of cells
* Reduced anion exchange Figure 3 - A representation of the steps involved in the entry of Plasmodium falciparum into an erythrocyte.
* Partial intracellular depletion of ATP
* A reduction in expression of multiple antigens

These changes are thought to give rise to the scientifically and clinically interesting phenomenon that those with SAO exhibit: a marked in vivo resistance to infection by the causative pathogen of malaria, Plasmodium falciparum. Unlike those with the Leach phenotype of common hereditary elliptocytosis (see above), there is a clinically significant reduction in both disease severity and prevalence of malaria in those with SAO. Because of this, the 35% incidence rate of SAO along the north coast of Madang Province in Papua New Guinea, where malaria in endemic, is a good example of natural selection.[4]

The reasons behind the resistance to malaria become clear when given an explanation the way in which Plasmodium falciparum invades its host. This parasite is an obligate intracellular parasite, which must enter the cells of the host it is invading. The band 3 proteins aggregate on the cell membrane at the site of entry, forming a circular orifice that the parasite squeezes through. These band 3 proteins act as receptors for the parasite. Normally a process much like endocytosis occurs, and the parasite is able to isolate itself from the intracellular proteins that are toxic to it while still being inside an erythrocyte (see figure 2). The increased rigidity of the erythrocyte membrane in SAO is thought to reduce the capacity of the band 3 proteins to cluster together, thereby making it more difficult for the malaria parasite to properly attach to and enter the cell. The reduced free ATP within the cell has been postulated as a further mechanism behind which SAO creates a hostile environment for Plasmodium falciparum.[citation needed]

## Diagnosis

[edit]

This section needs expansion. You can help by adding to it. (April 2021)

|

Diagnosis is based on presence of ovalocytes on a peripheral blood smear in absence of haemolysis, and should be differentiated from other forms of hereditory elliptocytosis and hereditary spherocytosis. Genetic assays such as PCR amplification may be used to confirm mutation of the SLC4A1 gene.[5]

## Treatment

[edit]

This section needs expansion. You can help by adding to it. (April 2021)

|

Homozygous SAO appears to be largely incompatible with life, although there have been reports of individuals surviving till adolescence with prompt intervention.[6][7]

Patients with heterozygous SAO are largely asymptomatic or may present with only compensated haemolytic anemia, hence treatment is generally not necessary. Patients with severe haemolytic anemia may require splenectomy.[citation needed]

## See also

[edit]

* Hereditary elliptocytosis
* Sickle-cell disease
* List of hematologic conditions

## References

[edit]

1. ^ Wrong, O; Bruce, LJ; Unwin, RJ; Toye, AM; Tanner, MJA (July 2002). "Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocytosis". Kidney International. 62 (1): 10–19\. doi:10.1046/j.1523-1755.2002.00417.x. PMID 12081559.
2. ^ Allen, S. J.; Clegg, J. B.; Alpers, M. P.; Mgone, C. S.; Peto, T. E.; O'Donnell, A.; Weatherall, D. J.; Alexander, N. D. (1999). "Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3 -- Allen et al. 60 (6): 1056 -- American Journal of Tropical Medicine and Hygiene". The American Journal of Tropical Medicine and Hygiene. 60 (6): 1056–1060\. doi:10.4269/ajtmh.1999.60.1056. PMID 10403343. S2CID 35681267.
3. ^ Liu, S.C.; Palek, J; Nichols, PE; Derick, LH; Chiou, SS; Amato, D; Corbett, JD; Golan, DE (1 July 1995). "Molecular basis of altered red blood cell membrane properties in Southeast Asian ovalocytosis: role of the mutant band 3 protein in band 3 oligomerization and retention by the membrane skeleton". Blood. 86 (1): 349–58\. doi:10.1182/blood.V86.1.349.bloodjournal861349. PMID 7795244.
4. ^ Mgone, Cs; Koki, G; Paniu, Mm; Kono, J; Bhatia, Kk; Genton, B; Alexander, Nd; Alpers, Mp (May 1996). "Occurrence of the erythrocyte band 3 (AE1) gene deletion in relation to malaria endemicity in Papua New Guinea". Transactions of the Royal Society of Tropical Medicine and Hygiene. 90 (3): 228–31\. doi:10.1016/S0035-9203(96)90223-0. ISSN 0035-9203. PMID 8758056.
5. ^ RESERVED, INSERM US14-- ALL RIGHTS. "Orphanet: Southeast Asian ovalocytosis". www.orpha.net. Retrieved 2021-04-21.`{{cite web}}`: CS1 maint: numeric names: authors list (link)
6. ^ Paquette, A. M.; Harahap, A.; Laosombat, V.; Patnode, J. M.; Satyagraha, A.; Sudoyo, H.; Thompson, M. K.; Yusoff, N. M.; Wilder, J. A. (August 2015). "The evolutionary origins of Southeast Asian Ovalocytosis". Infection, Genetics and Evolution. 34: 153–159\. doi:10.1016/j.meegid.2015.06.002. ISSN 1567-7257. PMID 26047685.
7. ^ Lavinya, Amanda A.; Razali, Ruzzieatul A.; Razak, Munirah A.; Mohamed, Rashidah; Moses, Emmanuel J.; Soundararajan, Meera; Bruce, Lesley J.; Eswaran, Jeyanthy; Yusoff, Narazah Mohd (2020-11-12). "Homozygous Southeast Asian Ovalocytosis in five live-born neonates". Haematologica. Online ahead of print (6): 1758–1761\. doi:10.3324/haematol.2020.268581. ISSN 1592-8721. PMC 8168517. PMID 33179475.

## External links

[edit]

Classification|

* ICD-10: D58.1
* ICD-9-CM: 282.1
* OMIM: 109270
* MeSH: C566230
* DiseasesDB: 9416

|

* v
* t
* e

Diseases of red blood cells

| Polycythemia|

* Polycythemia vera

|

| Anemia|

| Nutritional|

* Micro-: Iron-deficiency anemia
* Plummer–Vinson syndrome

* Macro-: Megaloblastic anemia
* Pernicious anemia

|

Hemolytic
(mostly normo-)|

| Hereditary|

* enzymopathy: Glucose-6-phosphate dehydrogenase deficiency
* glycolysis
* pyruvate kinase deficiency
* triosephosphate isomerase deficiency
* hexokinase deficiency

* hemoglobinopathy: Thalassemia
* alpha
* beta
* delta
* Sickle cell disease/trait
* Hemoglobin C disease
* membrane: Hereditary spherocytosis
* Minkowski–Chauffard syndrome
* Hereditary elliptocytosis
* Southeast Asian ovalocytosis
* Hereditary stomatocytosis

|

Acquired|

| AIHA|

* Warm antibody autoimmune hemolytic anemia
* Cold agglutinin disease
* Donath–Landsteiner hemolytic anemia
* Paroxysmal cold hemoglobinuria
* Mixed autoimmune hemolytic anemia

|

* membrane
* paroxysmal nocturnal hemoglobinuria

* Microangiopathic hemolytic anemia
* Thrombotic microangiopathy
* Hemolytic–uremic syndrome

* Drug-induced autoimmune
* Drug-induced nonautoimmune

* Hemolytic disease of the newborn

Aplastic
(mostly normo-)|

* Hereditary: Fanconi anemia
* Diamond–Blackfan anemia

* Acquired: Pure red cell aplasia
* Sideroblastic anemia
* Myelophthisic

Blood tests|

* Mean corpuscular volume
* normocytic
* microcytic
* macrocytic
* Mean corpuscular hemoglobin concentration
* normochromic
* hypochromic

Other|

* Methemoglobinemia
* Sulfhemoglobinemia
* Reticulocytopenia
* Hereditary persistence of fetal hemoglobin

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template